ZOMACTON 4mg & 10 mg
ZOMACTON® (somatropin) is Ferring’s recombinant human growth hormone (hGH) product, indicated for Growth Hormone Deficiency in children, and for Turner’s syndrome.
ZOMACTON 4mg is widely available, and Ferring is currently developing a 10 mg vial in addition. This new formulation will allow lower injection volume. It is anticipated that the indications for ZOMACTON 10 mg will be the same as for the current 4mg product.
ZOMACTON is delivered using innovative no-needle delivery devices. ZOMACTON 4mg is administered using the ZOMAJET® 2 VISION, and the new presentation ZOMACTON 10mg is planned to be administered using the ZOMAJET VISION X. Both these no-needle devices are easy and convenient to use.
Frost & Sullivan, the leading market research & consulting group, has recognised Ferring's innovation in this field with a prestigious award in March 2009. For more information on this, please see the related press release.